Home / Products / Pharmacopoeial impurities / Rifaximin Impurity B

Rifaximin Impurity B

CAS 1351775-03-5 Cat. no. RA-R006003 On synthesis

A pharmacopoeial impurity reference standard for this drug substance, characterised by HPLC, mass spectrometry and 1H NMR, and released with a lot-specific certificate of analysis.

Molecular formulaC43H49N3O11
Molecular weight783.86 g/mol
Available packsOn request
DocumentationCOA · SDS · spec sheet
StorageSee certificate

No price is published: pack size, documents and shipping are confirmed in one quotation.

Chemical structure of Rifaximin Impurity B, CAS 1351775-03-5

What this record covers

Rifaximin Impurity B (CAS 1351775-03-5) is supplied as a pure organic reference material under ISO 17034:2016 (ANAB, AR-2832). Each lot is weighed, dispensed and released against a specification that includes identity by mass spectrometry and 1H NMR, and purity by HPLC.

Typical use

Related-substance method development and validation, identification of impurity peaks in this drug substance drug substance, system suitability, and quantitative calibration where a defined reference is required.

Shipping and storage

Shipped worldwide with the SDS and, where applicable, a non-hazardous declaration. Cold-chain and dry ice are used when the material requires it; the storage condition and retest date are stated on the lot certificate rather than assumed from the catalogue.

Identifiers: catalogue RA-R006003 · CAS 1351775-03-5 · formula C43H49N3O11 · MW 783.86. If you need a different pack size or a co-lot certificate, ask — both are routine.

Other standards for this drug substance